ALKIM.ISALKIM.ISIST
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank69
3Y CAGR-71.2%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-71.2%/yr
vs +257.5%/yr prior
Acceleration
-328.7pp
Decelerating
Percentile
P69
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q3 2025 | 15.82% |
| Q2 2025 | 0.86% |
| Q1 2025 | 29.37% |
| Q4 2024 | -20.15% |
| Q3 2024 | 21.86% |
| Q2 2024 | 17.59% |
| Q1 2024 | -18.58% |
| Q4 2023 | 93.17% |
| Q3 2023 | 7.63% |
| Q2 2023 | 28.32% |
| Q1 2023 | 44.78% |
| Q4 2022 | -87.38% |
| Q3 2022 | 661.65% |
| Q2 2022 | 41.43% |
| Q1 2022 | 38.87% |
| Q4 2021 | -3.94% |
| Q3 2021 | 7.66% |
| Q2 2021 | 8.24% |
| Q1 2021 | 5.80% |
| Q4 2020 | -3.74% |
| Q3 2020 | -20.90% |
| Q2 2020 | 31.36% |
| Q1 2020 | 15.69% |
| Q4 2019 | -11.50% |
| Q3 2019 | 12.87% |
| Q2 2019 | 10.53% |
| Q1 2019 | -83.88% |
| Q4 2018 | -2.04% |
| Q3 2018 | 4.81% |
| Q2 2018 | 32.00% |
| Q1 2018 | 396.72% |
| Q4 2017 | 0.57% |
| Q3 2017 | -7.45% |
| Q2 2017 | 11.67% |
| Q1 2017 | 0.87% |
| Q4 2016 | -1.21% |
| Q3 2016 | 6.52% |
| Q2 2016 | 4.89% |
| Q1 2016 | -1.68% |
| Q4 2015 | -4.78% |